Skip to content

Expression and significance of cytokines in peripheral blood and bone microenvironment in Kummell's disease, osteoporotic vertebral compression fractures and non-osteoporotic patients

Clinical and basic study of osteoporotic vertebral fracture

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075907
Enrollment
Unknown
Registered
2023-09-19
Start date
2022-10-01
Completion date
Unknown
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporotic vertebral fracture

Interventions

Osteoprosis vertebral compression fracture:N/A
Kummell disease:N/A
Non-osteoporosis:N/A

Sponsors

the Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
63 Years to 80 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria for osteoporotic vertebral compression fractures were as following: (1) age = 50 years with symptomatic low back pain without any neurological symptoms or signs; (2) Computer Tomography(CT)or Magnetic Resonance Imaging(MRI)showed fresh vertebral compression fractures (evidenced by vertebral compression or collapse); (3) bone mineral density(BMD T-score = -2.5. The inclusion criteria for Kummell's disease were as following: (1) age = 50 years with symptomatic low back pain, without any neurological symptoms or signs; (2) CT or MRI displayed vertebral collapse with bone necrosis as well as positive signs of intravertebral cleft and double-line ; (3) BMD T-score = -2.5. The inclusion criteria for the control group were: (1) age = 50 years; (2) BMD T-score > -2.5.

Exclusion criteria

Exclusion criteria: (1) patients with malignant tumors, severe coagulation disorders, or hematological diseases; (2) patients with bacterial or viral infections such as pneumonia, influenza,human immunodeficiency virus( HIV), hepatitis B, etc., stroke, or acute myocardial infarction; (3) Patients with hepatic and renal insufficiency; (4) patients who have been treated with glucocorticoids or immunosuppressive agents for a long time, or those with immune dysfunction; (5) secondary vertebral compression fractures caused by presence of other diseases such as vertebral tumors or tuberculosis; (6) patients suffering with endocrine diseases (such as Cushing's syndrome, hyperthyroidism, hyperparathyroidism, Paget's disease); (7) patients who cannot tolerate surgery or have refused to participate in this study.

Design outcomes

Primary

MeasureTime frame
IL-1;IL-6;TNF-a;TGF-ß;

Countries

China

Contacts

Public ContactSong Wang

the Affiliated Hospital of Southwest Medical University

jasewangspine@swmu.edu.cn+86 138 8273 3086

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026